Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Chosa Oncology AB | CHOSA | Sep 30, 2024 | 1.01 | -8.18 |
ChromoGenics | CHRO | Sep 30, 2024 | 9.78 | 0.00 |
Cibus Nordic Real Estate | CIBUS | Sep 30, 2024 | 176.10 | -0.76 |
Cinclus Pharma Holding AB | CINPHA | Sep 30, 2024 | 28.03 | +0.11 |
Cinis Fertilizer AB | CINIS | Sep 30, 2024 | 21.05 | +1.20 |
Cint Group | CINT | Sep 30, 2024 | 9.84 | -0.35 |
CirChem | CIRCHE | Sep 30, 2024 | 2.65 | -1.85 |
Circle Energy Sweden B | CIRCLEB | Sep 30, 2024 | 0.00 | 0.00 |
Clas Ohlson B | CLASB | Sep 30, 2024 | 168.60 | +0.96 |
Clavister Holding | CLAV | Sep 30, 2024 | 1.76 | +2.62 |
Clean Motion | CLEMO | Sep 30, 2024 | 0.56 | -2.61 |
Clemondo Group | CLEM | Sep 30, 2024 | 0.83 | +2.47 |
Climeon B | CLIMEB | Sep 30, 2024 | 0.61 | -0.49 |
Clinical Laserthermia Systems B | CLSB | Sep 30, 2024 | 5.26 | +7.35 |
Cloetta | CLAB | Sep 30, 2024 | 24.46 | +1.75 |
Cloudberry Clean Energy ASA | CLOUDO | Sep 30, 2024 | 12.74 | 0.00 |
CodeMill | CDMIL | Sep 30, 2024 | 17.80 | -2.73 |
Coegin Pharma | COEGIN | Sep 30, 2024 | 4.33 | +11.03 |
CoinShares International Limited | CS | Sep 30, 2024 | 56.90 | -0.18 |
Combigene | COMBI | Sep 30, 2024 | 2.80 | +14.75 |
Combinedx | CX | Sep 30, 2024 | 38.70 | +2.11 |
Comintelli | COMINT | Sep 30, 2024 | 2.50 | +8.70 |
Compodium | COMPDM | Sep 30, 2024 | 8.30 | +3.75 |
Concejo B | CNCJOB | Sep 30, 2024 | 44.80 | -4.88 |
Concentric | COIC | Sep 30, 2024 | 219.00 | -0.91 |
Condo Nordic Holding AB | CONDO | Sep 30, 2024 | 1.82 | 0.00 |
Consensus B | CAMB | Sep 30, 2024 | 11.85 | +2.16 |
Coor Service Management Holding | COOR | Sep 30, 2024 | 45.08 | -1.49 |
Corem Property Group A | COREA | Sep 30, 2024 | 10.20 | -0.49 |
Corem Property Group B | COREB | Sep 30, 2024 | 10.37 | +1.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.